BUSINESS

• SymBio Earns Sales Milestone for Bendamustine from Taiwanese Firm
  July 13, 2016

• “Limited Potential for Growth through Domestic Business Alone” Is Reason for Acquiring US Generic Maker: Nichi-Iko Pres.
  July 13, 2016

• AnGes MG to Develop Chimera Decoy for World’s 1st Simultaneous Inhibition of Multiple Targets as Anti-Inflammatory Therapies
  July 13, 2016

• Ono Gets Rights to Celyad’s Allogeneic CAR T-cell Therapy
  July 12, 2016

• Kyorin to Copromote Allergy Drug Desloratadine with Kaken
  July 12, 2016

• Medreich’s Japan-Bound Generics Plant in India Completed: Meiji
  July 12, 2016

• Nichi-Iko to Buy Sagent for US$736 Million
  July 12, 2016

• 1st Patients Randomized in PII Cell Therapy Trial for Traumatic Brain Injury: SanBio
  July 12, 2016

• Ethical Drug Sales Up 5.8% in May: Crecon Report
  July 12, 2016

• Kyorin Eager to Resurrect Drug Discovery Prowess, Says President
  July 11, 2016

• Nippon Chemiphar to Boost Generic Production to 2 Billion Tablets by FY2018: President
  July 11, 2016

• NTD Collaboration with Astellas Began by Coincidence: Merck Global Health R&D Chief
  July 11, 2016

• Adcetris Approved for Add’l Indication in Europe: Takeda
  July 8, 2016

• Pfizer Adjusting Shipments of Certain Olanzapine Generics Due to Shortage
  July 8, 2016

• Heptares Earns US$10 Million Milestone on 1st Dosing of Immuno-Oncology Candidate
  July 7, 2016

• Parkinson’s Drug Opicapone Approved in Europe: Ono
  July 7, 2016

• AnGes MG Reports Disappointing Data for Nucleic Acid Drug, Filing Plan Now Back on Drawing Board
  July 7, 2016

• Kyorin Anticipates Annual Growth of “at Least 3%” through New Drugs Despite Patent Loss for Kipres: President
  July 7, 2016

• Oncolys, Nagoya Univ. to Jointly Research Combo Therapy of OBP-301, Checkpoint Inhibitor
  July 6, 2016

• Taisho Acquires 24.5% Stake in Vietnamese Drug Maker
  July 6, 2016

ページ

• « 先頭
• ‹ Prev
• …
• 475
• 476
• 477
• 478
• 479
• 480
• 481
• 482
• 483
• …
• Next ›
• 最終 »